131 related articles for article (PubMed ID: 24329001)
1. Antitumor activity of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, is highly dependent on its primary structure and steric configuration.
Zhao J; Ling X; Cao S; Liu X; Wan S; Jiang T; Li F
Mol Pharm; 2014 Feb; 11(2):457-67. PubMed ID: 24329001
[TBL] [Abstract][Full Text] [Related]
2. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
[TBL] [Abstract][Full Text] [Related]
3. An intravenous (i.v.) route-compatible formulation of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, improves FL118 antitumor efficacy and therapeutic index (TI).
Ling X; Li F
Am J Transl Res; 2013; 5(2):139-54. PubMed ID: 23573360
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and In Vitro/In Vivo Anti-Cancer Activities of Novel (20
Dai X; Wu G; Zhang Y; Zhang X; Yin R; Qi X; Li J; Jiang T
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187360
[TBL] [Abstract][Full Text] [Related]
5. Discovery of survivin inhibitors and beyond: FL118 as a proof of concept.
Li F
Int Rev Cell Mol Biol; 2013; 305():217-52. PubMed ID: 23890383
[TBL] [Abstract][Full Text] [Related]
6. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.
Ling X; Wu W; Fan C; Xu C; Liao J; Rich LJ; Huang RY; Repasky EA; Wang X; Li F
J Exp Clin Cancer Res; 2018 Oct; 37(1):240. PubMed ID: 30285798
[TBL] [Abstract][Full Text] [Related]
7. Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?
Li F
Am J Cancer Res; 2014; 4(3):304-11. PubMed ID: 24959385
[TBL] [Abstract][Full Text] [Related]
8. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
[TBL] [Abstract][Full Text] [Related]
9. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
Westover D; Ling X; Lam H; Welch J; Jin C; Gongora C; Del Rio M; Wani M; Li F
Mol Cancer; 2015 Apr; 14():92. PubMed ID: 25928015
[TBL] [Abstract][Full Text] [Related]
10. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H
Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity.
Wang W; Ling X; Wang R; Xiong H; Hu L; Yang Z; Wang H; Zhang Y; Wu W; Singh PK; Wang J; Li F; Li Q
J Med Chem; 2023 Dec; 66(24):16888-16916. PubMed ID: 38100041
[TBL] [Abstract][Full Text] [Related]
12. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.
Ling X; Xu C; Fan C; Zhong K; Li F; Wang X
Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388
[TBL] [Abstract][Full Text] [Related]
13. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis.
Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G
Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585
[TBL] [Abstract][Full Text] [Related]
14. Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX.
Thangaiyan R; Aljahdali IA; Lent-Moore KY; Liao J; Ling X; Li F
Am J Transl Res; 2021; 13(7):7458-7474. PubMed ID: 34377229
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
Li F; Ling X; Harris DL; Liao J; Wang Y; Westover D; Jiang G; Xu B; Boland PM; Jin C
Am J Cancer Res; 2017; 7(2):370-382. PubMed ID: 28337384
[TBL] [Abstract][Full Text] [Related]
16. Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer.
Tang Z; Ji L; Han M; Xie J; Zhong F; Zhang X; Su Q; Yang Z; Liu Z; Gao H; Jiang G
Life Sci; 2020 Sep; 257():118065. PubMed ID: 32659366
[TBL] [Abstract][Full Text] [Related]
17. Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
Santha S; Ling X; Aljahdali IAM; Rasam SS; Wang X; Liao J; Wang J; Fountzilas C; Li Q; Qu J; Li F
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217967
[TBL] [Abstract][Full Text] [Related]
18. FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models.
Ling X; Liu X; Zhong K; Smith N; Prey J; Li F
Am J Transl Res; 2015; 7(10):1765-81. PubMed ID: 26692923
[TBL] [Abstract][Full Text] [Related]
19. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of FL118 and 9-Q20 cytotoxicity and cellular uptake in 2D and 3D different cell models.
Weng Q; Zhou L; Xia L; Zheng Y; Zhang X; Li F; Li Q
Cancer Chemother Pharmacol; 2019 Sep; 84(3):527-537. PubMed ID: 31030236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
